文献速递胸部肿瘤放疗放疗物理与技术

肺癌立体定向消融放疗一站式服务:早期非小细胞肺癌试点研究

Stereotactic Ablative Radiotherapy (SABR) one stop service for lung cancer: A pilot study for early-stage Non-Small-Cell Lung Cancer (NSCLC).
PubMed 文献 · Radiother Oncol · 2026-04-29

本研究评估早期肺癌患者能否在单个工作日内完成模拟定位、计划和单次30 Gy立体定向消融放疗(SABR),并调查患者接受度。10例患者中9例在8小时目标窗口内完成治疗,中位总时间6小时50分,全部10例表达整体满意并认为比常规多日流程更方便。同日单次SABR可行且患者可接受,适合居住地远离治疗中心或多次就诊有困难者。

要点

  • 10例早期肺癌患者中9例在8小时工作时间内完成同日单次30 Gy SABR。
  • 中位从CT模拟开始至治疗结束时间为6小时50分(IQR 6小时42分至7小时4分)。
  • 全部10例患者表达整体满意,并认为比常规治疗流程更方便。

核心结论

  • 同日单次30 Gy SABR在早期肺癌患者中可行且患者可接受,适合居住地远离治疗中心或多次就诊有困难者考虑。

研究设计与样本

  • 可行性试点研究,由放射肿瘤科医生、放疗治疗师和医学物理师组成多学科团队制定单工作日完成模拟定位、计划与治疗的工作流程。
  • 共治疗10例早期肺癌患者,其中女6例、男4例,中位年龄76.5岁,9例被判定为医学上不可手术。
  • 处方剂量为30 Gy,患者于治疗后两周内完成体验调查。
  • 研究设定双主要终点:可行性(10例中7例在8个工作小时内完成治疗)和患者满意度(10例中7例表达整体满意)。

主要发现

  • 10例患者中9例在目标8小时窗口内完成治疗,达到可行性终点。
  • 从CT模拟开始至治疗结束的中位时间为6小时50分(IQR 6小时42分至7小时4分)。
  • 全部10例患者表达对该服务的整体满意,达到满意度终点。
  • 全部10例患者认为该流程比常规治疗流程更方便。

关键数值与推荐

  • 处方剂量为30 Gy,单次照射。
  • 可行性终点为10例中7例在8个工作小时内完成治疗,实际10例中9例达标。
  • 满意度终点为10例中7例表达整体满意,实际10例全部满意。

临床怎么用

  • 对居住地远离治疗中心或多次就诊有困难的早期肺癌患者,可考虑同日单次SABR路径。
  • 实施需多学科团队(放射肿瘤科医生、放疗治疗师、医学物理师)协作制定单日工作流程并全程计时。
  • 治疗后两周内用体验调查评估患者满意度与接受度。

局限性

  • 为试点可行性研究,样本量仅10例,未设对照或长期疗效终点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Single-fraction stereotactic ablative radiotherapy (SABR) is a curative treatment option for patients with early lung cancer. We undertook a feasibility study to assess whether simulation, planning and treatment could be undertaken within a single day and whether this expedited pathway was acceptable to patients. METHODS: A multidisciplinary team of radiation oncologists, radiation therapists and medical physicists developed a workflow to permit all aspects of planning and treatment to be conducted within a single working day. All aspects of the pathway were timed. Prescription dose was 30 Gray. Patients completed an Experience Survey within two weeks of treatment. The study would be deemed successful if it met both dual primary endpoints of feasibility (7/10 patients treated within 8 working hours) and patient satisfaction (7/10 expressing overall satisfaction). RESULTS: Ten patients were treated. These included 6 women and 4 men. Median age was 76.5 and 9 patients had been deemed to be medically inoperable. Median time from commencement of CT simulation to end of treatment was 6 h 50 min (IQR 6 h 42 m - 7 h 4 m); 9/10 patients were treated within the target 8-hour window. All 10 patients expressed overall satisfaction with the service. All 10 felt it was more convenient than our usual treatment pathway would have been. CONCLUSION: Same-day single-fraction SABR is feasible and acceptable to patients. This pathway should be considered for those who live a significant distance from treatment centres or who have other difficulties in attending for multiple visits.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Wallace ND, Burns M, Devereux T, et al. Stereotactic Ablative Radiotherapy (SABR) one stop service for lung cancer: A pilot study for early-stage Non-Small-Cell Lung Cancer (NSCLC). Radiother Oncol. 2026. PMID: 42067067. doi:10.1016/j.radonc.2026.111553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。